Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Other Non-current Assets
Long-term assets not reported separately.
No reported Other Non-current Assets figures are available to summarize.
Other Non-current Assets history
Currency unavailable · from the balance sheet
No Other Non-current Assets data reported for this period type.
Other Non-current Assets vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $8.07M USD | +2681.0% | — | 0.9% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $3.28M USD | -14.9% | +88.2% | 0.6% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €2.21M EUR | — | — | 1.3% |
| Mar 2026 | $256K USD | +0.0% | +0.0% | 0.1% | |
| Mar 2026 | $231K USD | -92.7% | — | 0.1% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $128K USD | +24.3% | +78.9% | 0.0% |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +0.0% | +78.9% | 0.1% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.